We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Two Biosimilar Guidances on FDA’s 2013 Agenda But No Interchangeability
Two Biosimilar Guidances on FDA’s 2013 Agenda But No Interchangeability
February 12, 2013
The FDA plans to release two guidances to assist biosimilar sponsors this year, but drugmakers hoping for advice on how to achieve the coveted interchangeable designation shouldn’t get their hopes up.